The Juravinski Cancer Centre is a comprehensive centre for cancer care and cancer research in Hamilton, Ontario, Canada. Operated by Hamilton Health Sciences, it is adjacent to the Juravinski Hospital, which provides emergency department facilities.

There are 125 beds in Cancer Care Ontario-Hamilton Regional Cancer Centre.

During the past decade, Cancer Care Ontario-Hamilton Regional Cancer Centre conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Care Ontario-Hamilton Regional Cancer Centre" #1 sponsor was "Radiation Therapy Oncology Group" with 34 trials, followed by "NCIC Clinical Trials Group" with 13 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored and "University Health Network, Toronto" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Care Ontario-Hamilton Regional Cancer Centre" #1 collaborator was "National Cancer Institute (NCI)" with 41 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Care Ontario-Hamilton Regional Cancer Centre" are "Head and Neck Cancer" (10 trials), "Lung Cancer" (7 trials), "Prostate Cancer" (7 trials), "Metastatic Cancer" (6 trials) and "Ovarian Cancer" (6 trials). Many other conditions were trialed in "Cancer Care Ontario-Hamilton Regional Cancer Centre" in a lesser frequency.

Most popular intervention types in "Cancer Care Ontario-Hamilton Regional Cancer Centre" are "Drug" (46 trials), "Radiation" (35 trials), "Procedure" (19 trials), "Biological" (10 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (30 trials), "cisplatin" (10 trials), "conventional surgery" (10 trials), "filgrastim" (7 trials) and "paclitaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Care Ontario-Hamilton Regional Cancer Centre" are 47 trials for "All" genders, 8 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Care Ontario-Hamilton Regional Cancer Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in Cancer Care Ontario-Hamilton Regional Cancer Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Care Ontario-Hamilton Regional Cancer Centre, 10 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".